2019 Analysis of the Worldwide Vaccine Adjuvants Market - ResearchAndMarkets.com

DUBLIN--()--The "Global Vaccine Adjuvants Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

The Global Vaccine Adjuvants market is expected to reach $1442.60 million by 2026 growing at a CAGR of 12.3% during 2018 to 2026. Vaccine adjuvant is an immunological agent that is added to the vaccine to provide long-lasting protection against antigen and enhance the immune response. Vaccine adjuvant can modify the effect of other agents.

Some of the factors such as increasing government recommendations for immunizations and technological advancements in aluminum hydroxide based adjuvants are fuelling the market growth. However, stringent regulatory environment and time-consuming approvals is restraining the market growth.

Based on Application, Research Application segment has witnessed significant growth due to the factors such as ongoing research projects on new adjuvants, increasing activities by government bodies and organizations, increasing usage of vaccine adjuvants commercially, and high occurrences of zoonotic diseases.

The key vendors mentioned are Agenus Inc, Avanti Polar Lipids Inc, Brenntag Biosector A/S (A Subsidiary of Brenntag AG), CSL Limited, Invivogen, MVP Laboratories Inc, Novavax Inc, OZ Biosciences, Seppic (A Subsidiary of Air Liquide Group) and SPI Pharma Inc (A Subsidiary of Associated British Foods PLC).

Key Questions Answered in this Report:

  • How this market evolved since the year 2016
  • Market size estimations, forecasts and CAGR for all the segments presented in the scope
  • Key Market Developments and financials of the key players
  • Opportunity Analysis for the new entrants
  • SWOT Analysis of the key players
  • Fastest growing markets analyzed during the forecast period

Key Topics Covered:

1 Market Synopsis

2 Research Outline

2.1 Research Snapshot

2.2 Research Methodology

2.3 Research Sources

2.3.1 Primary Research Sources

2.3.2 Secondary Research Sources

3 Market Dynamics

3.1 Drivers

3.2 Restraints

4 Market Environment

4.1 Bargaining power of suppliers

4.2 Bargaining power of buyers

4.3 Threat of substitutes

4.4 Threat of new entrants

4.5 Competitive rivalry

5 Global Vaccine Adjuvants Market, By Disease Type

5.1 Introduction

5.2 Cancer

5.3 Infectious Diseases

6 Global Vaccine Adjuvants Market, By Route of Administration

6.1 Introduction

6.2 Intradermal Route

6.3 Intramuscular Route

6.4 Intranasal Route

6.5 Oral Route

6.6 Subcutaneous Route

7 Global Vaccine Adjuvants Market, By Application

7.1 Introduction

7.2 Commercial Application

7.3 Research Application

8 Global Vaccine Adjuvants Market, By Product

8.1 Introduction

8.2 Adjuvant Emulsions

8.3 Combination Adjuvants

8.4 Particulate Adjuvants

8.5 Pathogen Components

9 Global Vaccine Adjuvants Market, By Type

9.1 Introduction

9.2 Adjuvant Emulsions

9.3 Bacteria-derived Adjuvants

9.4 Carbohydrate Adjuvants

9.5 Liposome Adjuvants

9.6 Mineral Salt-based Adjuvant

9.7 Organic Adjuvants

9.8 Tensoactive Adjuvants

9.9 Virus-like Particles (VLP)

10 Global Vaccine Adjuvants Market, By Mechanism of Action

10.1 Introduction

10.2 Active Immunostimulants

10.3 Carriers

10.4 Vehicle Adjuvants

11 Global Vaccine Adjuvants Market, By Geography

11.1 North America

11.2 Europe

11.3 Asia Pacific

11.4 South America

11.5 Middle East & Africa

12 Strategic Benchmarking

13 Vendors Landscape

13.1 Agenus Inc

13.2 Avanti Polar Lipids Inc

13.3 Brenntag Biosector A/S (A Subsidiary of Brenntag AG)

13.4 CSL Limited

13.5 Invivogen

13.6 MVP Laboratories Inc

13.7 Novavax Inc

13.8 OZ Biosciences

13.9 Seppic (A Subsidiary of Air Liquide Group)

13.10 SPI Pharma Inc (A Subsidiary of Associated British Foods PLC)

For more information about this report visit https://www.researchandmarkets.com/r/m5tk5b

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900